Gilron | Biomedical and Molecular Sciences | School of Medicine

Ian Gilron MD, MSc, FRCPC

Position(s)

Professor

Director of Clinical Pain Research

Contact Info

Faculty Bio

Ian Gilron is the Director of Clinical Pain Research, Professor of Anesthesiology, and Biomedical Sciences, and Faculty in the Centre for Neuroscience Studies at Queen’s University in Kingston, Ontario, Canada. He has received continuous funding from the Canadian Institutes of Health Research, and from the PSI Foundation (Ontario), since 2000 to support research, and research training programs, which study the mechanisms of, and treatments for, chronic and acute pain. Work from Dr. Gilron’s research team at Queen’s University has been published in the New England Journal of Medicine, Lancet, CMAJ, Pain, Anesthesiology and other journals. He has also co-authored neuropathic pain treatment guidelines from the Canadian Pain Society (2014) and the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain (2015). Dr. Gilron is a Councillor of the International Association for the Study of Pain (iasp-pain.org); serves on the Executive Committee of the Analgesic “ACTTION” partnership (acttion.org)' and is one of the Principal Investigators of the CIHR Strategy for Patient-Oriented Research Chronic Pain Network.

Research Interests

Our long-term academic goals are to improve the clinical management of pain by advancing knowledge about mechanisms, treatments and functional impact of painful conditions. Using a translational ("bench-to-bedside-to-bench") approach, these goals are being addressed by research programs in the areas listed below:

Analgesic drug combinations in acute and chronic pain

Differential mechanisms & treatment responses of spontaneous vs. stimulus-evoked pain

Impact of pain conditions and pain treatment on function and work-related outcomes

Gender differences in pain reporting and pain treatment response

Selected publications

Gilron I. Methodological issues associated with clinical trials in neuropathic pain. Expert Rev Clin Pharmacol 2016 Epub ahead of print] PubMed; PMID: 27659719.

Hoffer D, Smith SM, Parlow J, Allard R, Gilron I. Adverse event assessment and reporting in trials of newer treatments for post-operative pain. Acta Anaesthesiol Scand 2016;60:842.

Gilron I, Chaparro LE, Tu D, Holden RR, Milev R, Towheed T, DuMerton-Shore D, Walker S. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain 2016;157:1532.

Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment.Mayo Clin Proc 2015;90:532.

Gilron I, Tu D, Holden RR, Jackson AC, DuMerton-Shore D. Combination of morphine with nortriptyline for neuropathic pain. Pain 2015;156:1440.

Gilron I, Kehlet H. Prevention of chronic pain after surgery: new insights for future research and patient care. Can J Anaesth 2014;61:101.

Gilron I, Jensen TS, Dickenson AH. Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol 2013;12:1084.

Chaparro LE, Smith SA, Moore RA, Wiffen PJ, Gilron I. Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev 2013;7:CD008307.

Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain. Lancet 2009;374:1252.

Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324.

Team

Faculty Bio

Research Interests

Selected publications

Faculty